Specific Antinociceptive Activity of Cholest-4-en-3-one, Oxime (TRO19622) in Experimental Models of Painful Diabetic and Chemotherapy-Induced Neuropathy-Reference-Cited by-同舟云学术

Specific Antinociceptive Activity of Cholest-4-en-3-one, Oxime (TRO19622) in Experimental Models of Painful Diabetic and Chemotherapy-Induced Neuropathy

Published:2008-05-20 Issue:2 Volume:326 Page:623-632
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Bordet Thierry,Buisson Bruno,Michaud Magali,Abitbol Jean-Louis,Marchand Fabien,Grist John,Andriambeloson Emile,Malcangio Marzia,Pruss Rebecca M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. C-fiber mechanical stimulus–response functions are different in inflammatory versus neuropathic hyperalgesia in the rat

2. Interleukin-6 attenuates the development of experimental diabetes-related neuropathy

3. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

4. Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in small molecule Nav 1.7 inhibitors for cancer pain management;Bioorganic Chemistry;2024-09

2. Examination of the effects of vitexin and vitexin-loaded solid lipid nanoparticles on neuropathic pain and possible mechanisms of action;Neuropharmacology;2024-08

3. Novel combination of Olesoxime/Resveratrol-encapsulated exosomes to improve cognitive function by targeting amyloid β-induced Alzheimer’s disease: investigation on in vitro and in vivo model;Inflammopharmacology;2024-05-16

4. Use of kersetin and fisetin flavonoids in combination with pregabalin and gabapentin in the treatment of neuropathic pain;Journal of Pharmacy and Pharmacology;2024-04-08

5. Olesoxime protects against cisplatin-induced acute kidney injury by attenuating mitochondrial dysfunction;Biomedical Journal;2024-04